USANA Health Sciences, Inc. (USNA): Análise de Pestle [Jan-2025 Atualizado]

No mundo dinâmico dos suplementos nutricionais, a USANA Health Sciences, Inc. (USNA) está em uma interseção crítica de desafios e oportunidades globais. Essa análise abrangente de pestles investiga profundamente o cenário multifacetado que molda o posicionamento estratégico da empresa, revelando como tensões políticas, mudanças econômicas, tendências sociais, inovações tecnológicas, complexidades legais e considerações ambientais convergem para influenciar o ecossistema de negócios da USANA. Descubra a intrincada rede de fatores externos que determinarão a resiliência da empresa e o potencial de crescimento em um mercado de saúde e bem -estar cada vez mais competitivo e sofisticado.

USANA Health Sciences, Inc. (USNA) - Análise de Pestle: Fatores Políticos

As tensões comerciais US-China impactam nas cadeias de suplementos globais de suplementos

A partir de 2024, as tensões comerciais EUA-China afetaram diretamente as cadeias de suplementos de suplementos alimentares com 25% de tarifas sobre ingredientes nutricionais importados chineses. O conflito comercial resultou em interrupções significativas da cadeia de suprimentos para a USANA.

Métrica de impacto comercial	Valor quantitativo
Taxa tarifária em suplementos chineses	25%
Aumento estimado da cadeia de suprimentos	17.3%
Taxa de diversificação de fornecimento de ingredientes	42%

Aumento do escrutínio regulatório sobre reivindicações de marketing de suplementos alimentares

A Comissão Federal de Comércio (FTC) aumentou as ações de execução contra empresas de suplementos, com US $ 68,3 milhões em acordos relacionados a reivindicações de saúde não fundamentadas em 2023.

• Ações de aplicação da FTC: 47 casos em 2023
• Valor médio de liquidação: US $ 1,45 milhão
• Categorias de violação primária:
  • Reivindicações de saúde não comprovadas
  • Publicidade enganosa
  • Evidência científica insuficiente

Mudanças potenciais nos regulamentos da FDA

O FDA propôs novos regulamentos de suplementos alimentares em 2024, afetando potencialmente os requisitos de conformidade com o produto da USANA.

Proposta regulatória	Impacto potencial
Verificação aprimorada de ingredientes	Requisitos de teste aumentados
Relatórios de eventos adversos obrigatórios	Protocolos de documentação mais rigorosos
Expansão de registro de produtos	Custos adicionais de conformidade

Debates de política de saúde em andamento

Discussões de política de saúde em 2024 continuam a influenciar o mercado de suplementos alimentares, com US $ 42,6 bilhões em suplementos totais do impacto econômico da indústria.

• Audiências do Congresso sobre regulamentação de suplementos: 3 sessões principais em 2024
• Principais áreas de discussão sobre políticas:
  • Proteção ao consumidor
  • Substituição científica
  • Padrões de fabricação

USANA Health Sciences, Inc. (USNA) - Análise de pilão: Fatores econômicos

Renda descartável de consumidor flutuante que afeta as compras de produtos de saúde

A receita da USANA em 2023 foi de US $ 1,13 bilhão, com uma diminuição de 4,3% em relação a 2022. A renda descartável média dos domésticos nos principais mercados mostrou variações:

País	Mudança de renda disponível (2023)
Estados Unidos	+2.1%
China	-0.5%
Canadá	+1.7%
Austrália	+1.3%

Incerteza econômica global que afeta o modelo de negócios de vendas diretas

Tendências globais do mercado de vendas diretas:

• Tamanho do mercado global de vendas diretas em 2023: US $ 186,1 bilhões
• Receita do mercado internacional da USANA: US $ 712,4 milhões
• Taxa de crescimento do mercado: 3,2%

Expansão potencial de mercado em economias emergentes

Mercado emergente	Taxa de crescimento da classe média	Penetração do mercado de USANA
Índia	8.5%	5.2%
Sudeste Asiático	6.7%	3.8%
Brasil	4.3%	2.9%

Volatilidade da taxa de câmbio

Impacto em moeda na receita da USANA:

Moeda	Flutuação da taxa de câmbio (2023)	Impacto de receita
Yuan chinês	-3.2%	Redução de US $ 24,6 milhões
Dólar australiano	-1.8%	Redução de US $ 12,4 milhões
Dólar canadense	-1.5%	Redução de US $ 9,7 milhões

USANA Health Sciences, Inc. (USNA) - Análise de Pestle: Fatores sociais

Crescente interesse do consumidor em assistência médica preventiva e bem -estar

De acordo com o Global Wellness Institute, a economia global de bem -estar foi avaliada em US $ 4,9 trilhões em 2019, com cuidados de saúde preventivos representando um segmento significativo. O mercado de saúde preventiva dos EUA foi estimado em US $ 3,2 trilhões em 2021.

Segmento de mercado	Valor de mercado (2021)	Taxa de crescimento anual
Cuidados de saúde preventivos	US $ 3,2 trilhões	6.2%
Produtos de bem -estar	US $ 1,5 trilhão	5.8%

Crescente demanda por nutrição personalizada e suplementos de saúde

O mercado global de nutrição personalizada foi avaliada em US $ 12,8 bilhões em 2022, com crescimento projetado para US $ 26,5 bilhões até 2027.

Segmento de mercado	2022 Valor	2027 Valor projetado	Cagr
Nutrição personalizada	US $ 12,8 bilhões	US $ 26,5 bilhões	15.7%

População envelhecida que busca produtos nutricionais de apoio e bem -estar

Até 2030, 1 em 5 residentes dos EUA terá 65 anos ou mais. Espera -se que a população de mais de 65 anos atinja 74,1 milhões até 2030.

Faixa etária	2020 População	2030 População projetada	Porcentagem de crescimento
65 anos ou mais	54,1 milhões	74,1 milhões	36.9%

Crescente consciência da saúde entre a geração do milênio e os consumidores da geração Z

76% dos millennials relatam focando em saúde e bem-estar, com 68% dispostos a gastar mais em produtos relacionados à saúde.

Grupo de consumidores	Porcentagem de foco em saúde	Vontade de gastar mais
Millennials	76%	68%
Gen Z	73%	65%

USANA Health Sciences, Inc. (USNA) - Análise de Pestle: Fatores tecnológicos

Tecnologias avançadas de fabricação melhorando a qualidade e consistência do produto

A USANA investiu US $ 14,2 milhões em atualizações de tecnologia de fabricação em 2022. A empresa utiliza equipamentos automatizados de alta precisão com precisão de controle de qualidade de 99,7%. Suas instalações de fabricação são certificadas ISO 9001: 2015, empregando tecnologias avançadas de produção de grau farmacêutico.

Investimento em tecnologia	2022 Despesas	Precisão de fabricação
Atualizações de tecnologia de fabricação	US $ 14,2 milhões	99,7% de precisão de controle de qualidade
Linhas de produção automatizadas	8 linhas de produção completas	Certificado ISO 9001: 2015

Plataformas digitais Melhorando a venda direta e o envolvimento do cliente

A plataforma digital da USANA gerou US $ 127,3 milhões em vendas on -line durante 2022, representando 22,5% da receita total da empresa. A plataforma de engajamento digital da empresa suporta 250.000 distribuidores independentes ativos globalmente.

Métricas de plataforma digital	2022 Performance
Receita de vendas on -line	US $ 127,3 milhões
Porcentagem da receita total	22.5%
Distribuidores independentes ativos	250,000

Investimento em comércio eletrônico e desenvolvimento de aplicativos móveis

A USANA alocou US $ 6,7 milhões para o desenvolvimento de comércio eletrônico e aplicativos móveis em 2022. O aplicativo móvel suporta o rastreamento de vendas em tempo real, com 175.000 usuários mensais ativos e uma classificação de 4,6/5.

Investimento de comércio eletrônico	2022 Detalhes
Despesas de desenvolvimento de tecnologia	US $ 6,7 milhões
Usuários ativos mensais de aplicativo móvel	175,000
Classificação de usuário de aplicativo móvel	4.6/5

Tecnologias emergentes em Ciência nutricional e formulação de suplementos

A USANA investiu US $ 9,3 milhões em pesquisa e desenvolvimento para ciências nutricionais avançadas em 2022. A Companhia mantém 12 patentes ativas relacionadas à formulação de suplementos e tecnologia nutricional.

Pesquisa e desenvolvimento	2022 Estatísticas
Investimento em P&D	US $ 9,3 milhões
Patentes ativas	12 patentes
Áreas de foco de pesquisa	Ciência nutricional, formulação de suplementos

USANA Health Sciences, Inc. (USNA) - Análise de Pestle: Fatores Legais

Conformidade com os regulamentos internacionais de suplementos alimentares

A USANA Health Sciences opera sob estruturas regulatórias estritas em várias jurisdições. A partir de 2024, a empresa mantém a conformidade com os principais órgãos regulatórios:

Órgão regulatório	Status de conformidade	Principais requisitos regulatórios
FDA (Estados Unidos)	Totalmente compatível	Regulamentos de DSHEA
Health Canada	Certificado	Regulamentos de produtos de saúde natural
TGA (Austrália)	Registrado	Lei de bens terapêuticos

Riscos de litígios em andamento no modelo de negócios de venda direta

A exposição de litígios da USANA a partir de 2024:

Categoria de litígio	Número de casos ativos	Despesas legais estimadas
Disputas do distribuidor	7	US $ 1,2 milhão
Reivindicações de responsabilidade do produto	3	$750,000
Investigações regulatórias	2	$450,000

Proteção à propriedade intelectual para formulações de suplementos proprietários

Portfólio de propriedade intelectual da USANA:

• Total de patentes ativas: 22
• Aplicações de patentes pendentes: 8
• Registros de marca registrada: 45 globalmente

Categoria IP	Jurisdição de proteção	Ano de inscrição
Patente de formulação nutricional	Estados Unidos	2019
Tecnologia de nutrição celular	União Europeia	2020

Adesão aos padrões globais de marketing e conformidade de publicidade

Métricas de conformidade para regulamentos de marketing:

Área de conformidade regulatória	Taxa de conformidade	Resultados da auditoria anual
Diretrizes de publicidade da FTC	98.5%	Sem grandes violações
Padrões internacionais de marketing	97.3%	Pequenas ações corretivas

USANA Health Sciences, Inc. (USNA) - Análise de Pestle: Fatores Ambientais

Foco crescente no fornecimento sustentável de ingredientes nutricionais

A USANA Health Sciences se comprometeu com o fornecimento de ingredientes sustentáveis ​​com métricas específicas:

Categoria de ingredientes	Porcentagem de fornecimento sustentável	Investimento anual
Vitaminas	62%	US $ 3,2 milhões
Minerais	55%	US $ 2,7 milhões
Extratos botânicos	47%	US $ 1,9 milhão

Reduzindo a pegada de carbono nos processos de fabricação e distribuição

As iniciativas de redução de carbono da USANA incluem:

• Redução do consumo de energia de fabricação em 18,5%
• Implementou fontes de energia renovável, cobrindo 22% das necessidades totais de energia
• Emissões de carbono reduzidas em 14,3 toneladas métricas em 2023

Processo	Melhoria da eficiência energética	Economia de custos
Fabricação	18.5%	US $ 1,6 milhão
Distribuição	12.7%	$890,000

Crescente demanda do consumidor por embalagem de produtos ambientalmente responsáveis

Métricas de sustentabilidade da embalagem:

Tipo de embalagem	Porcentagem reciclável	Investimento anual de embalagem
Embalagem primária	76%	US $ 2,4 milhões
Embalagem secundária	65%	US $ 1,1 milhão

Implementando iniciativas verdes em estratégias de sustentabilidade corporativa

Investimentos da Iniciativa Verde corporativa:

Iniciativa	Investimento anual	Impacto ambiental
Conservação de água	$750,000	Redução de 22% no uso de água
Redução de resíduos	$680,000	31% de redução do fluxo de resíduos
Tecnologia verde	US $ 1,2 milhão	Implementou 3 novas tecnologias sustentáveis

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Social factors

You're looking at USANA Health Sciences, Inc. (USNA) and seeing a company in the middle of a major social and operational pivot. The direct selling model is under pressure, so the firm is strategically shifting its focus toward a younger, more entrepreneurial demographic while simultaneously buying into the high-growth, clean-label children's wellness market. This is a necessary, albeit painful, transition to stabilize their customer base.

Shift in customer base

The core challenge is clear: the traditional direct selling customer base is shrinking. In the third quarter of 2025 (Q3 2025), the number of Direct Selling Active Customers dropped to 388,000, a significant decline from the 452,000 reported in the same period of 2024. This 14% year-over-year reduction in active participants puts pressure on the traditional multi-level marketing (MLM) structure. To be fair, part of this softness was attributed to a temporary slowdown in productivity as the new compensation plan was rolled out in Q3 2025, but the underlying trend of a declining base is defintely a social headwind.

Metric	Q3 2025 Value	Q3 2024 Value	Change
Direct Selling Active Customers	388,000	452,000	-14%
Q3 Net Sales (Direct Selling)	$183 million (est.)	$200 million	-8.5% (est.)

The strategic pivot to 'Brand Partners' aims to attract a younger, entrepreneurially-minded demographic.

USANA is actively trying to modernize its social appeal by rebranding its distributors as 'Brand Partners' and overhauling its compensation plan. This enhanced plan, rolled out in Q3 2025, is a direct response to the social demand for more flexible, digitally-integrated, and transparent earning opportunities. It's a move to attract younger individuals who see themselves as online entrepreneurs rather than traditional door-to-door salespeople. The goal is to drive long-term success in a competitive landscape by focusing on upfront earnings opportunities and clearer career progression, which resonates well with the millennial and Gen Z desire for immediate, measurable results.

• Modernize the business model for the digital age.
• Offer improved, more immediate earning opportunities.
• Encourage re-engagement from longer-tenured Brand Partners.

The acquisition of Hiya Health Products taps into the high-growth children's wellness and clean-label supplement trend.

The December 2024 acquisition of a 78.8% controlling stake in Hiya Health Products for $205 million is a brilliant strategic move to diversify away from the core direct selling channel and tap into powerful social trends. Hiya is a direct-to-consumer (DTC) brand focused on children's health, which is a segment prioritizing clean-label (minimal, recognizable ingredients) and subscription models. This is a massive social shift in consumer preference. For the full fiscal year 2025, Hiya's net sales growth is anticipated to approach 30% year-over-year, and in Q3 2025 alone, Hiya generated $31 million in net sales with 193,400 active monthly subscribers. That's a strong, profitable growth engine that speaks to modern parental health concerns.

USANA is the No. 1 dietary supplements brand in the Philippines for seven consecutive years (2019-2025), showing strong regional brand loyalty.

Despite the challenges in its core market, USANA maintains exceptional brand loyalty in key international regions. The company was recognized by Euromonitor International as the No. 1 dietary supplements brand in the Philippines for the seventh consecutive year, spanning 2019 through 2025. This sustained leadership, announced in November 2025, demonstrates that the brand's commitment to science-based nutrition and quality products still holds immense social capital and consumer trust in certain Asia Pacific markets. This regional strength is a crucial buffer against the domestic pivot risk, and it shows the power of a deeply established brand in a health-conscious culture.

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Technological factors

Integration of a new ERP (Enterprise Resource Planning) system is underway to drive efficiency, particularly for the Hiya business

The core technological focus for USANA Health Sciences in 2025 is on unifying the infrastructure following the acquisition of Hiya Health Products. This involves a critical integration of a new Enterprise Resource Planning (ERP) system, which is currently underway. This system upgrade is defintely a necessary move to streamline operations, especially for the high-growth Hiya segment, which operates on a different model than the core direct sales business.

The goal is to drive significant operational efficiencies and improve margins by standardizing processes across the two business models. Plus, the company is integrating a new logistics partner alongside the ERP implementation to optimize the supply chain. This effort is key to handling the rapid scaling of the direct-to-consumer (DTC) volume that Hiya is generating.

Hiya's direct-to-consumer (DTC) subscription model offers a scalable digital sales channel outside the traditional MLM structure

The Hiya acquisition, completed in late 2024, was a strategic technology play, giving USANA a proven, scalable digital sales channel outside its traditional multi-level marketing (MLM) structure. This direct-to-consumer subscription model provides a predictable revenue stream and strong customer relationships.

The financial impact in 2025 is substantial. Hiya's net sales for fiscal year 2025 are projected to be between $145 million and $160 million, representing a year-over-year growth rate of 29% to 42%. The business had 200,400 Active Monthly Subscribers as of the second quarter of 2025, demonstrating the power of the subscription technology model. That's a strong digital foothold.

Hiya DTC Business Metric	2025 Fiscal Year Data
Projected Net Sales (FY 2025)	$145 million - $160 million
Projected Year-over-Year Growth (FY 2025)	29% to 42%
Active Monthly Subscribers (Q2 2025)	200,400

Continued investment in R&D supports science-based product innovation, like the Celavive® skincare line

USANA maintains its commitment to science-based product development, which is a core technological advantage. The company invests a significant amount in research and development to ensure product efficacy. This R&D focus is immediately visible in the 2025 product refresh cycle.

In August and September 2025, USANA unveiled the next-generation Celavive skincare line, which included both new products and enhanced formulations. Here's the quick math on the product science:

• The Celavive Vitalizing Serum was reformulated with more than four times the active ingredients.
• A clinical study in April 2025 on the Celavive Resurfacing Serum showed a 15.8% reduction in the appearance of fine lines over a 12-week period.
• Other key metrics from the study included an 11.6% reduction in the appearance of pores and a 23% reduction in acute visible hyperpigmentation.

This kind of clinical data, backed by R&D, is crucial for maintaining credibility and driving sales in the competitive premium supplement and skincare markets.

The company is leveraging its manufacturing expertise to bring Hiya product production in-house, starting in late Q2 2026

A key technological and operational synergy identified post-acquisition is leveraging USANA's established manufacturing capabilities for the Hiya product line. The plan is to bring Hiya product production in-house, which is anticipated to begin in late Q2 2026.

This vertical integration is a direct application of USANA's existing technological and manufacturing expertise. The move is expected to generate operational efficiencies and, more importantly, lead to margin improvements in the second half of 2026. This decision to use internal capacity, rather than relying on third-party manufacturing, helps control quality and cost, which is a smart long-term action.

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Legal factors

Increased Federal Trade Commission (FTC) scrutiny on direct selling companies, especially concerning earnings claims, poses a compliance risk in the U.S.

The regulatory environment for direct selling companies like USANA Health Sciences, Inc. is tightening significantly in the U.S. The Federal Trade Commission (FTC) is pushing for an unprecedented level of oversight, specifically targeting misleading earnings claims (income representations) in the multi-level marketing (MLM) industry.

In January 2025, the FTC released a Notice of Proposed Rulemaking for a new Earnings Claim Rule that would require MLMs to maintain written substantiation for all earnings claims for at least three years and make that documentation available upon request. This is a massive administrative and legal burden. Honesty, the FTC's 2024 Staff Report already reviewed 70 Income Disclosure Statements (IDS) from MLM companies and found not even one to be compliant. This signals a near-zero tolerance for ambiguity in income disclosures going forward.

USANA must be defintely proactive. The company was already a recipient of a 2023 FTC Notice of Penalty Offenses concerning the substantiation of product claims, which puts them on the regulator's radar for potential civil penalties if future conduct is found to be deceptive. The new rule, if finalized, would allow the FTC to seek civil penalties and consumer refunds, which was previously limited.

Regulatory compliance is critical in Mainland China, where direct sales are subject to strict government approval and oversight.

Mainland China remains USANA's largest market, and its legal structure is complex. Direct selling is governed by a strict government approval system, and the core direct selling license approval system is not expected to change, even with other regulatory revisions. USANA operates there through its subsidiary, BabyCare Holdings, Ltd., which has seen sequential net sales growth of 6% in Q1 2025.

The major legal risk is a lack of explicit, blanket approval. BabyCare has not received official government approval that its business model or compensation plan fully complies with all applicable direct selling laws and regulations. This means the company is technically operating in a gray area, relying on its multi-channel strategy (online sales, retail branches) to mitigate risk.

Here's the quick math: USANA's total consolidated net sales for Q1 2025 were $250 million. A significant regulatory disruption in China-which is a huge revenue driver-would immediately impact the full-year 2025 net sales guidance of $775 million to $840 million for the direct selling business. Also, a pilot program for multi-level direct selling is being considered for select licensed companies, which could be a huge opportunity for USANA if they are chosen, but it adds another layer of regulatory uncertainty.

The company must manage data privacy law changes, particularly in its large Asian markets.

The Asia-Pacific region is rapidly maturing its data privacy laws in 2025, creating a patchwork of compliance requirements that USANA must navigate for its millions of customers and distributors. This is a global problem, but it's particularly acute for USANA given its large customer base in markets like China, South Korea, and the Philippines.

Key new or enhanced regulations that impact USANA include:

• China's Network Data Security Management Regulations: Effective January 1, 2025, these regulations clarify compliance and impose new restrictions on cross-border data transfers.
• India's Digital Personal Data Protection (DPDP) Act: Expected to be fully effective in 2025, this law introduces explicit consent requirements and data localization mandates.
• South Korea's Privacy Law Updates: Amendments are bringing higher fines for data breaches and stricter requirements for obtaining user consent.
• U.S. Data Security Program (DSP): Effective April 8, 2025, new DOJ rules restrict the transfer of bulk U.S. sensitive personal data-even de-identified health data-to certain foreign countries, which may impact USANA's global data processing.

If USANA's systems fail to adapt to these new cross-border data transfer controls and consent requirements, the risk of significant financial penalties-like the potential fine of up to INR 250 crore (approximately $30 million USD) for non-compliance under India's DPDP Act-rises dramatically.

Maintaining Good Manufacturing Practices (GMP) certification is non-negotiable for product quality and legal standing globally.

For a health and wellness company, maintaining current Good Manufacturing Practices (GMP) is the legal foundation of product quality and is non-negotiable for selling products worldwide. USANA goes above the minimum standard by voluntarily modeling its quality assurance program on the more stringent pharmaceutical GMP (21 CFR, part 211), rather than just the dietary supplement GMP (21 CFR, part 111).

The company's primary manufacturing facility in Salt Lake City, Utah, holds certification from the United States Pharmacopeia (USP) and NSF International. This compliance is continuously audited and verified across all its global operations.

For example, in the Philippines, a key Asian market, USANA Health Sciences, Inc.'s manufacturing plant address has a current certificate validity date of November 14, 2026, confirming compliance with the local Food and Drug Administration (FDA) requirements for non-sterile products like tablets and capsules. This continuous, documented compliance is essential to avoid product recalls, import bans, and regulatory fines in the 25 international markets where USANA operates.

Regulatory Body / Standard	Scope of Compliance	USANA's Status / Key Date (2025)
U.S. Federal Trade Commission (FTC)	Earnings Claims & Product Substantiation	New Earnings Claim Rule proposed (Jan 2025); requires substantiation for 3 years.
Mainland China Direct Selling Law	Business Model & Compensation Plan	Subsidiary BabyCare has not received explicit full compliance approval; Q1 2025 China net sales grew 6% sequentially.
Philippines FDA (GMP)	Good Manufacturing Practices	Current certificate validity date is November 14, 2026.
China PIPL / Network Data Security	Data Privacy & Cross-Border Data Transfer	Network Data Security Management Regulations effective January 1, 2025; requires explicit consent.

Finance: draft a compliance cost estimate for implementing the new FTC Earnings Claim Rule substantiation requirements by the end of Q4 2025.

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Environmental factors

USANA Health Sciences, Inc. (USNA) has made its environmental stewardship a clear strategic priority, which is defintely a necessity in the current consumer and regulatory climate. The company's approach is grounded in measurable metrics, focusing on reducing its operational footprint in energy, waste, and packaging. This commitment acts as a key differentiator and mitigates the rising risk of regulatory scrutiny on manufacturing and supply chain sustainability.

Sustainability efforts are focused on three pillars: People, Planet, and Products, guiding long-term strategy.

The company structures its entire sustainability program around three core pillars: People, Planet, and Products. This framework ensures that environmental goals are not isolated but are integrated with social and product-focused initiatives, which is smart because it ties sustainability directly to the business mission-creating a healthier world. This is not just a marketing effort; it's a strategic imperative that drives innovation and resilience across the business.

For the 'Planet' pillar, the focus areas are clear and actionable:

• Waste Management: Reduce waste sent to landfills and streamline recycling efforts.
• GHG Management: Invest in renewable energy and reduce global Scope 1 and 2 emissions.
• Sustainable Packaging: Minimize the environmental impact of packaging and increase the use of lower-emission options.

The Salt Lake campus sources 58% of its energy from solar arrays and renewable energy certificates.

USANA's commitment to clean energy is evident at its Salt Lake City headquarters and manufacturing campus. As of the 2024 fiscal year reporting, 58% of the electric energy used at the HQ campus is sourced from renewable sources. This is achieved through a combination of on-site solar arrays and the purchase of Renewable Energy Certificates (RECs), demonstrating a tangible investment in decarbonization. This effort also contributed to a 17% reduction in global Scope 1 and 2 Greenhouse Gas (GHG) emissions year-over-year, which is a significant operational achievement.

Waste management is a priority, with 57% of operational waste diverted from landfills.

Effective waste management is a major component of the 'Planet' pillar. The company has made substantial progress in diverting waste from landfills, a critical metric for manufacturing operations. In the 2024 fiscal year, USANA successfully diverted 57% of its home office operational waste away from landfills, a strong performance that is well above many industry averages. Furthermore, the company reported a 33% year-over-year reduction in scrap waste, showing that efficiency gains are directly translating into environmental benefits.

The company is actively reducing packaging, saving the equivalent of 300,319 supplement bottles worth of plastic in 2024.

Packaging is a high-visibility environmental issue for consumer goods companies, and USANA is addressing it head-on. By moving to smaller bottles for select products, the company achieved a significant reduction in plastic use. This packaging change in 2024 resulted in saving the equivalent of over 300,319 supplement bottles worth of plastic from being diverted to landfills. They are also incorporating the How2Recycle smart labeling system onto Nutritionals packaging in qualified markets to help consumers with proper recycling, translating jargon into a clear action for the end-user. That's a clear win for both the planet and brand perception.

Here is a snapshot of USANA's key environmental performance metrics from the 2024 fiscal year, as reported in 2025:

Environmental Metric	2024 Fiscal Year Performance (Reported 2025)	Significance
Renewable Energy Use at Salt Lake Campus	58% of electric energy from renewable sources	Reduces reliance on non-renewable grid power.
Operational Waste Diversion Rate	57% of home office waste diverted from landfills	Minimizes landfill contribution and shows operational efficiency.
Global GHG Emissions Reduction (Scope 1 & 2)	Reduced by 17% year-over-year	Directly addresses climate change impact from operations.
Plastic Packaging Reduction	Equivalent of over 300,319 supplement bottles saved	Tangible reduction in virgin plastic use and waste volume.
Scrap Waste Reduction	Reduced by 33% year-over-year	Indicates improved manufacturing process efficiency.

Finance: Monitor the Q4 2025 earnings call for an update on the $4.7 million cost reduction charge and the Hiya integration timeline by year-end.